In depression, EA exerts effects on neuropeptides and neurotransmitters; proinflammatory cytokines; serum copper, zinc, calcium and magnesium levels; the HPA axis; BDNF; signaling pathways; the genome; and hippocampal synaptic plasticity. This evidence concerns the gene BDNF and depressive symptom measurement.